Restore Brain

News & Insights

Stay informed about TMS therapy, Spravato, and mental health. Expert perspectives from our clinical team.

What Is Restore Brain? Interventional Psychiatry Explained
0:36
TMS TherapyReel

What Is Restore Brain? Interventional Psychiatry Explained

John Cavanagh introduces Restore Brain — a clinic specializing in treatment-resistant depression using cutting-edge interventional psychiatry, including TMS and other treatments that go beyond traditional medication.

Watch
Bipolar vs. Major Depression: Why It Matters
1:48
Mental HealthReel

Bipolar vs. Major Depression: Why It Matters

Bipolar disorder often starts as adolescent depression and is frequently misdiagnosed as MDD. Knowing the difference is critical because antidepressants can trigger dangerous manic episodes in bipolar patients.

Watch
Dopamine, ADHD, and the Risk of Substance Use
0:42
Mental HealthReel

Dopamine, ADHD, and the Risk of Substance Use

Low dopamine drives hyperactivity, impulsivity, and risk-taking behavior — and can increase the likelihood of substance use disorder. Understanding dopamine is key to understanding ADHD.

Watch
How App Gamification Fuels Depression Through Dopamine
1:45
Mental HealthReel

How App Gamification Fuels Depression Through Dopamine

Tech companies deliberately exploit dopamine rewards to keep users hooked on apps and screens. This episode examines how engineered addiction contributes to rising depression rates across all ages.

Watch
How Depression Is Diagnosed: The 14-Day Criteria
0:55
Mental HealthReel

How Depression Is Diagnosed: The 14-Day Criteria

The DSM defines major depression based on symptoms lasting just 14 days. This episode questions whether that threshold truly captures chronic illness versus temporary life setbacks.

Watch
How Ketamine and TMS Repair the Brain
0:25
TMS TherapyReel

How Ketamine and TMS Repair the Brain

New therapies like ketamine, esketamine, and TMS focus on the brain's actual structure. Research shows ketamine may help grow new neurons, offering hope beyond traditional medications.

Watch
How Major Depressive Disorder Became a Diagnosis
0:45
Mental HealthReel

How Major Depressive Disorder Became a Diagnosis

Major Depressive Disorder first appeared in psychiatry's diagnostic manual in 1980. This episode traces how depression evolved from an unclassified condition to one of the most common diagnoses today.

Watch
How Ritalin Affects Dopamine and the Developing Brain
1:41
Mental HealthReel

How Ritalin Affects Dopamine and the Developing Brain

Ritalin works by increasing dopamine in people who are dopamine-deficient — which is why stimulants calm hyperactive patients rather than making them more hyper. Understanding this changes the ADHD conversation.

Watch
How TMS Gained Insurance Coverage
0:30
TMS TherapyReel

How TMS Gained Insurance Coverage

A look at how TMS therapy evolved from an uncovered procedure in 2012 to a widely recognized treatment that keeps patients out of hospitals and prevents therapeutic misadventures.

Watch
Spravato's Rapid-Onset Power Against Depression
1:10
SpravatoReel

Spravato's Rapid-Onset Power Against Depression

Unlike SSRIs that take weeks to work, Spravato (esketamine) provides rapid-onset antidepressant effects — critical for patients with suicidal thoughts who need immediate relief.

Watch
SSRIs and Doubled Suicide Risk in Adolescents
1:40
ResearchReel

SSRIs and Doubled Suicide Risk in Adolescents

Research shows SSRIs may double the risk of suicide in adolescents, making accurate diagnosis critical. TMS offers a safer alternative for teens whose depression may actually be early-stage bipolar disorder.

Watch
The Hidden Side Effects of SSRIs
2:46
Mental HealthReel

The Hidden Side Effects of SSRIs

Sexual dysfunction, weight gain, and emotional blunting are common but underreported SSRI side effects. This frank conversation explores why many patients abandon antidepressants.

Watch
TMS and Spravato: FDA-Cleared Treatments for Depression
0:18
TMS TherapyReel

TMS and Spravato: FDA-Cleared Treatments for Depression

An overview of two FDA-cleared therapies — Transcranial Magnetic Stimulation (TMS) and Spravato (esketamine) — and how they help patients recover from treatment-resistant depression.

Watch
TMS for Treatment-Resistant Depression
0:19
TMS TherapyReel

TMS for Treatment-Resistant Depression

TMS is indicated for treatment-resistant depression — patients who have failed multiple antidepressant classes — and also carries an indication for patients struggling with suicidal thoughts.

Watch
TMS Now Approved for Adolescents 15 and Older
0:33
TMS TherapyReel

TMS Now Approved for Adolescents 15 and Older

TMS therapy has been approved for adolescents aged 15 and above as an augmenting treatment, meaning teens may not need to endure multiple medication failures before trying TMS.

Watch
When Medications Fail: The Case for TMS
1:01
TMS TherapyReel

When Medications Fail: The Case for TMS

A candid discussion about the cycle of medication trials, the limitations of traditional prescribing, and how TMS emerged as a recognized alternative for treatment-resistant patients.

Watch
Why Antidepressants Don't Work for Most Patients
2:22
ResearchReel

Why Antidepressants Don't Work for Most Patients

Only a third of patients on antidepressants achieve a meaningful response, and prolonged use may actually worsen depression — a phenomenon called iatrogenic or tardive depression.

Watch
Why Primary Care Prescribing Often Falls Short
0:52
Mental HealthReel

Why Primary Care Prescribing Often Falls Short

Many patients arrive at psychiatric care after years of failed medication trials from primary care providers. This episode explores why seeing a specialist sooner can change outcomes.

Watch
Why the Serotonin Theory of Depression Is Wrong
2:32
ResearchReel

Why the Serotonin Theory of Depression Is Wrong

The decades-old theory that depression stems from serotonin deficiency hasn't held up. This episode explains how the antidepressant movement may have been built on a flawed observation from tuberculosis medications.

Watch
Why TMS Therapy Is Considered Safe and Effective
0:33
TMS TherapyReel

Why TMS Therapy Is Considered Safe and Effective

Approved since 2007 and adopted by Medicare in 2012, TMS therapy has a strong track record of safety, effectiveness, and minimal side effects for treating depression.

Watch
IMG
Clinic News

New St. Louis Location Now Open

Restore Brain is now serving patients in the greater St. Louis area. Our new clinic at 11477 Olde Cabin Rd offers both TMS therapy and Spravato treatment with the same patient-centered care our DFW patients know.

Read More
Spravato vs Ketamine: What's the Difference?
Research

Spravato vs Ketamine: What's the Difference?

Both target the glutamate system, but Spravato and IV ketamine differ in important ways — FDA approval, administration, insurance coverage, and safety protocols. Here's what patients should know.

Read More
Understanding TMS Therapy: A Complete Guide
TMS Therapy

Understanding TMS Therapy: A Complete Guide

Everything you need to know about Transcranial Magnetic Stimulation — how it works, what to expect, and who it can help. A comprehensive overview for patients considering TMS for treatment-resistant depression.

Read More